• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » On-X Life Technologies shareholders sue CryoLife over $10m escrow account

On-X Life Technologies shareholders sue CryoLife over $10m escrow account

June 2, 2017 By Brad Perriello

CryoLife, On-X TechnologiesThe shareholders of On-X Life Technologies yesterday accused CryoLife Inc. (NYSE:CRY) of trying to hold on to a $10 million escrow account connected with their merger last year.

CryoLife paid $130 million for On-X in January 2016, including the escrow account, which was meant to cover “On-X’s indemnification obligations relating to its representations and warranties in the merger agreement,” according to a lawsuit filed in the Delaware Chancery Court by Fortis Advisors, the firm representing the On-X shareholders.

The escrowed cash was slated to be turned over to On-X a year after the deal closed, but on Jan. 18 CryoLife sent a claim notice saying it would hold on to the money to cover $17 million in losses it said it incurred “as a result of On-X committing multiple acts of financial fraud, violating European labeling regulations, failing to properly terminate and transition supply contracts, failing to maintain proper quality controls, and failing to disclose millions of dollars in other liabilities from litigation over employment and personal injury matters,” according to the complaint.

“CryoLife did not provide a single document in support of the vague allegations in its claim notice, and, to make matters worse, CryoLife thwarted any attempt by Fortis to investigate those allegations. Indeed, after serving the claim notice, CryoLife threatened the On-X shareholders with legal action if they provided Fortis, or its counsel, with any information regarding the allegations in the claim notice,” the lawsuit alleged. “Instead, in an email to Fortis, CryoLife demanded that any requests for information be directed solely to CryoLife. Yet, when Fortis directed its information requests to CryoLife, as it had been instructed to do, CryoLife refused to produce a single document supporting the allegations in the claim notice.”

The June 1 suit asked the Chancery Court to order the release of the $10 million held in escrow, judgments and awards for breach of contract, pre- and post-judgment interest and legal costs.

Filed Under: Legal News, Mergers & Acquisitions, Replacement Heart Valves Tagged With: CryoLife, fortisadvisors, On-X Life Technologies

More recent news

  • FDA adds Gradient denervation tech to advisory program
  • Former Intuitive sales leader joins surgical robot maker Virtual Incision as CEO
  • Smith+Nephew to open first orthopedic ambulatory surgery center in the UK
  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy